Form 4 Filing for Mark H. Pavao - Coya Therapeutics, Inc.

This filing details a stock option grant to Mark H. Pavao, a director at Coya Therapeutics, Inc. The option, for 10,000 shares of common stock, was granted on April 9, 2026, with an exercise price of $4.53 per share. The option will vest fully on the first anniversary of the grant date, contingent upon continued service. The transaction is reported on Form 4, indicating a change in beneficial ownership. The reporting owner, Mark H. Pavao, is identified by CIK 0001297988. The issuer is Coya Therapeutics, Inc. (COYA).